Andreas P. Freidig

Metabolism: A Bottleneck in <i>In Vitro</i> Toxicological Test Development

Sandra Coecke, H J Ahr, Bas J. Blaauboer et al. · Alternatives to Laboratory Animals · 2006 · 177 citations

Pharmacy, Pharmacokinetics, Toxicology +6

Quantitative profiling of bile acids in biofluids and tissues based on accurate mass high resolution LC-FT-MS: Compound class targeting in a metabolomics workflow

I. Bobeldijk, Maarten Hekman, Jitske de Vries-van der Weij et al. · Journal of Chromatography B · 2008 · 111 citations

Life Sciences, Biochemistry, Pharmaceutical Analysis +17

Prediction of in vivo embryotoxic effect levels with a combination of in vitro studies and PBPK modelling

Miriam Verwei, Johan A. van Burgsteden, Cyrille Krul et al. · Toxicology Letters · 2006 · 109 citations

Pharmacy, Toxicology, Developmental Toxicology +15

Influence of pH and Other Modifying Factors on the Distribution Behavior of 4-Quinolones to Solid Phases and Humic Acids Studied by “Negligible-Depletion” SPME−HPLC

Hans‐Christian Holten Lützhøft, Wouter H. J. Vaes, Andreas P. Freidig et al. · Environmental Science & Technology · 2000 · 100 citations

Agriculture, Microbiology, Analytical Toxicology +12

A physiologically based biokinetic (PBBK) model for estragole bioactivation and detoxification in rat

Ans Punt, Andreas P. Freidig, Thierry Delatour et al. · Toxicology and Applied Pharmacology · 2008 · 97 citations

Pharmacy, Pharmacokinetics, Physiology +9